-
公开(公告)号：US11236159B2
公开(公告)日：2022-02-01
申请号：US15749775
申请日：2016-08-02
Applicant: Novartis AG
Inventor： Brian Boettcher , Shari Lynn Caplan , Regis Cebe , Guochun Li , John A. Taraszka , Fangmin Xu , David Langdon Yowe
Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
-
公开(公告)号：US20210139585A1
公开(公告)日：2021-05-13
申请号：US16877878
申请日：2020-05-19
Applicant: Novartis AG
Inventor： Brian Granda , Amy Rayo , Connie Hong , Dattananda Chelur , Haihui Lu , Regis Cebe , Sunyoung Jang
Abstract: The present disclosure provides CD19 binding molecules that specifically bind to CD19, including monospecific, bispecific and trispecific binding molecules, conjugates comprising the CD19 binding molecules, and pharmaceutical compositions comprising the CD19 binding molecules and the conjugates. The disclosure further provides methods of using the C19 binding molecules to treat diseases and disorders associated with expression of CD19. The disclosure yet further provides recombinant host cells engineered to express the CD19 binding molecules and methods of producing the CD19 binding molecules by culturing the host cells under conditions in which the CD19 binding molecules are expressed.
-
公开(公告)号：US20250000973A1
公开(公告)日：2025-01-02
申请号：US18684417
申请日：2022-08-19
Applicant: Novartis AG
Inventor： Michael Bardroff , Regis Cebe , Brian Walter Granda , Shyamali Jayashankar , Sandeep Tharian Koshy , Sandra Miller , Andrew Patrick Price , Amy Rayo , Darko Skegro , Louise Mary Treanor , Jennifer Yang
IPC: A61K39/00 , A61P35/00 , C07K14/705 , C07K14/725 , C07K16/28 , C12N5/0783
Abstract: The invention provides methods of making immune effector cells (for example, T cells, NK cells) that express a chimeric antigen receptor (CAR), and compositions generated by such methods.
-
公开(公告)号：US11685776B2
公开(公告)日：2023-06-27
申请号：US16483185
申请日：2018-03-01
Applicant: Novartis AG
Inventor： Regis Cebe , Sebastien Irigaray , Darko Skegro
CPC classification number: C07K16/244 , C07K16/2863 , C07K2317/31 , C07K2317/50 , C07K2317/522 , C07K2317/55 , C07K2317/60 , C07K2317/66
Abstract: The present invention provides heterodimeric antibodies and fragments thereof and methods for their preparation, wherein the pairing of heavy and light chains has been improved. Interface residues were mutated such that each light chain strongly favoured its cognate heavy chain when two different heavy chains and two different light chains were co-transfected and co-expressed in the same cell to assemble a functional, heterodimeric antibody or fragment thereof.
-
公开(公告)号：US10899844B2
公开(公告)日：2021-01-26
申请号：US15890302
申请日：2018-02-06
Applicant: Novartis AG
Inventor： Regis Cebe , Stephane Olland , David Langdon Yowe
IPC: C07K16/40 , A61K39/395 , C07K16/28 , A61K39/00
Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
-
Patent Agency Ranking
公开(公告)号：US12221481B2
公开(公告)日：2025-02-11
申请号：US16877878
申请日：2020-05-19
Applicant: Novartis AG
Inventor： Brian Granda , Amy Rayo , Connie Hong , Dattananda Chelur , Haihui Lu , Regis Cebe , Sunyoung Jang
Abstract: The present disclosure provides CD19 binding molecules that specifically bind to CD19, including monospecific, bispecific and trispecific binding molecules, conjugates comprising the CD19 binding molecules, and pharmaceutical compositions comprising the CD19 binding molecules and the conjugates. The disclosure further provides methods of using the C19 binding molecules to treat diseases and disorders associated with expression of CD19. The disclosure yet further provides recombinant host cells engineered to express the CD19 binding molecules and methods of producing the CD19 binding molecules by culturing the host cells under conditions in which the CD19 binding molecules are expressed.
-
公开(公告)号：US11802152B2
公开(公告)日：2023-10-31
申请号：US17539335
申请日：2021-12-01
Applicant: Novartis AG
Inventor： Brian Boettcher , Shari Lynn Caplan , Regis Cebe , Guochun Li , John A. Taraszka , Fangmin Xu , David Langdon Yowe
CPC classification number: C07K16/28 , A61P3/00 , A61K39/001107 , C07K2317/24 , C07K2317/34 , C07K2317/55 , C07K2317/92 , C07K2317/94 , C07K2318/00
Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
-
公开(公告)号：US20230302155A1
公开(公告)日：2023-09-28
申请号：US18022058
申请日：2021-08-20
Applicant: Novartis AG
Inventor： Sandeep Tharian Koshy , Glenn Dranoff , Maria Anna Sofia Broggi , Chris Bridgeman , Stephen Michael Canham , Yoel Melles , Regis Cebe , Brian Walter Granda , Louise Mary Treanor , Shyamali Jayashankar , Jennifer Yang , Amy Rayo , Andrew Patrick Price , Darko Skegro , Justine Guyot , Tushar Dattu Apsunde , Cameron Chuck-munn Lee , Michael Bardroff , Sandra Miller
IPC: A61K47/69 , A61K9/06 , A61K38/18 , C12N15/86 , A61K38/20 , A61K38/17 , C07K14/705 , C07K14/725 , C07K16/28 , A61K39/395 , A61K39/00 , A61K31/4745
CPC classification number: A61K47/6927 , A61K9/06 , A61K38/1858 , C12N15/86 , A61K38/2086 , A61K38/2046 , A61K47/6901 , A61K38/1774 , C07K14/70517 , C07K14/70578 , A61K38/177 , C07K14/70521 , C07K14/7051 , C07K16/2806 , C07K16/2818 , C07K16/2809 , A61K39/3955 , A61K39/4631 , A61K31/4745 , C12N2740/15043 , C12N2740/15071 , A61K2039/505 , C07K2319/33 , C07K2319/03 , A61K2239/21 , C07K2319/02 , A61K2239/22 , C07K2317/31 , A61K2239/29 , C07K2317/55 , C07K2317/622 , C07K2317/524 , C07K2317/526 , C07K2317/522 , A61K2039/545 , A61K2239/38 , A61K2239/13 , C07K2317/75
Abstract: Aspects of this disclosure relate generally to the use of biomaterials for the in vivo generation of CAR expressing cells. In some embodiments, the biomaterials comprise one or more of a cell recruitment composition, a viral vector, and/or a cell activation agent.
-
公开(公告)号：US11692046B2
公开(公告)日：2023-07-04
申请号：US17127600
申请日：2020-12-18
Applicant: Novartis AG
Inventor： Regis Cebe , Stephane Olland , David Langdon Yowe
IPC: C07K16/40 , C07K16/28 , A61K39/395 , A61K39/00
CPC classification number: C07K16/40 , A61K39/39591 , C07K16/2863 , A61K2039/505 , A61K2039/545 , C07K2317/24 , C07K2317/75 , C07K2317/92 , C07K2317/94
Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
-
公开(公告)号：US20210171659A1
公开(公告)日：2021-06-10
申请号：US17127600
申请日：2020-12-18
Applicant: Novartis AG
Inventor： Regis Cebe , Stephane Olland , David Langdon Yowe
IPC: C07K16/40 , A61K39/395 , C07K16/28
Abstract: The present disclosure relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.018 seconds)
